x

FG to Vaccinate 7.7m Girls In Nigeria Against Cervical Cancer

Must read

By Joyce Remi-Babayeju

The Federal Government of Nigeria today introduced the human Papillomavirus (HPV) vaccine into its routine immunization system, to vaccinate 7.7 million girls between the ages of 9 – 14.

The vaccination of 7.7 girls in Nigeria is against Cervical Cancer is the largest number in a single round of HPV vaccine drive in the African region.

Girls aged 9–14 years will receive a single dose of HPV vaccine, which is highly efficacious in preventing infection with HPV types 16 and 18 that are known to cause at least 70% of cervical cancers.

UNICEF stated that in Nigeria, cervical cancer is the third most common cancer and the second most frequent cause of cancer deaths among women aged between 15 and 44 years, while the country recorded 12 000 new cases, and 8000 deaths from cervical cancer in 2020.

The Coordinating Minister of Health and Social Welfare, Prof. Muhammad Ali Pate, said, ” The loss of about 8000 Nigerian women yearly from a disease that is preventable is completely unacceptable.”

‘ Cervical Cancer is mostly caused by HPV and parents can be HPV, and parents can avoid physical and financial pain by protecting their children with a single dose of vaccine.’
” Saving lives, and producing quality health outcomes and protecting the wellbeing of Nigerians are ventral to the Renewed Health Agenda of President Bola Ahmed Tinubu.”

“. The onset of the vaccination campaign is an opportunity to safeguard our girls from the scourge of cervical cancer many years into the future.”

” As a parent myself, I have four daughters, all of them have had the same HPV vaccine to protect them against cervical cancer. I’d like to implore fellow parents to dutifully ensure that this generation of our girls disrupt the preventable loss of lives to cervical cancer in addition to other untold hardship, loss, and pain”Prof. Pate said.

A five-day mass vaccination campaign in schools and communities follows the inaugural rollout in 16 states and the Federal Capital Territory before it is incorporated in routine immunization schedules at health facilities.

The second phase of the vaccination introduction is set to start in May 2024 in 21 states.

The vaccine is being provided for free by the Federal Ministry of Health through the National Primary Health Care Development Agency with support from Gavi, the Vaccine Alliance, United Nations Children’s Fund (UNICEF), World Health Organization (WHO) and other partners.

The WHO country office in Nigeria and other partners, over 35 000 health workers, have so far been trained in preparation for the campaign and subsequent vaccine delivery in all health facilities.

Meanwhile, the government has established Vaccination sites in all, 4163 wards across the 16 states included in the phase one rollout to ensure no eligible girl is left behind. Mobile vaccination units have also been set up to ensure that remote communities can access the vaccine.

WHO Representative in Nigeria, Dr. Walter Kazadi Mulombo said, “This is a pivotal moment in Nigeria’s efforts to lower the burden of cervical cancer – one of the few cancers which can potentially be eliminated through vaccination,” “We’re committed to supporting the government to increase access to the HPV vaccine to protect the health and well-being of the next generation of women.”

WHO further recommends HPV vaccination to be included in the national immunization programmes of countries where cervical cancer is a public health priority, where its cost-effective and sustainable implementation is feasible.

In line with this, Nigeria has moved to prioritize the addition of the vaccine to the country’s routine immunization schedule.

Copyright DAYBREAK.

All rights reserved. This material, and other digital content on this website, may not be reproduced, published, broadcast, rewritten or redistributed in whole or in part without prior express written permission from DAYBREAK NEWS.

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisement -

Latest article